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Non-viral generation of neural precursor-like cells from adult human fibroblasts 
Abstract 
Recent studies have reported direct reprogramming of human fibroblasts to mature neurons by the 
introduction of defined neural genes. This technology has potential use in the areas of neurological 
disease modeling and drug development. However, use of induced neurons for large-scale drug screening 
and cell-based replacement strategies is limited due to their inability to expand once reprogrammed. We 
propose it would be more desirable to induce expandable neural precursor cells directly from human 
fibroblasts. To date several pluripotent and neural transcription factors have been shown to be capable of 
converting mouse fibroblasts to neural stem/precursor-like cells when delivered by viral vectors. Here we 
extend these findings and demonstrate that transient ectopic insertion of the transcription factors SOX2 
and PAX6 to adult human fibroblasts through use of non-viral plasmid transfection or protein transduction 
allows the generation of induced neural precursor (iNP) colonies expressing a range of neural stem and 
pro-neural genes. Upon differentiation, iNP cells give rise to neurons exhibiting typical neuronal 
morphologies and expressing multiple neuronal markers including tyrosine hydroxylase and GAD65/67. 
Importantly, iNP-derived neurons demonstrate electrophysiological properties of functionally mature 
neurons with the capacity to generate action potentials. In addition, iNP cells are capable of 
differentiating into glial fibrillary acidic protein (GFAP)-expressing astrocytes. This study represents a 
novel virus-free approach for direct reprogramming of human fibroblasts to a neural precursor fate. 
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 Introduction 
Cellular differentiation and lineage commitment have 
traditionally been considered as robust and irreversible 
processes. Recent work however has demonstrated that 
mature somatic cells can be reprogrammed to a pluripotent 
embryonic stem cell-like state by forced expression of the 
stem cell associated genes OCT3/4, SOX2, KLF4 and/or C-
MYC.[1-3]  Using this technology, a range of cell types have 
been reprogrammed including human fibroblast cells, [2,4,5] 
keratinocytes, [6] mesenchymal cells, [7] peripheral blood cells 
,[8] melanocytes [9] and adipose stem cells. [10] In addition, it 
has been demonstrated that forced expression of lineage-
specific transcription factors can convert fibroblasts directly 
to blood progenitor cells, [11] mature cardiomyocytes, [12] 
hepatocyte-like cells [13], neural stem/precursor-like cells [14-18] 
and mature neurons [19-24] without first reverting to an 
intermediate pluripotent state. As such, somatic cell 
reprogramming provides a unique platform by which to 
dissect the molecular mechanisms that underlie epigenetic 
reprogramming and lineage specification as well as the 
exciting opportunity to personalize human cells for both 
research and clinical application.  
 
Several studies have reported direct reprogramming of 
human fibroblast cells to mature neurons by the introduction  
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Recent studies have reported direct reprogramming of human fibroblasts to mature neurons by the introduction of 
defined neural genes. This technology has potential use in the areas of neurological disease modeling and drug 
development. However, use of induced neurons for large-scale drug screening and cell-based replacement 
strategies is limited due to their inability to expand once reprogrammed. We propose it would be more desirable 
to induce expandable neural precursor cells directly from human fibroblasts. To date several pluripotent and 
neural transcription factors have been shown to be capable of converting mouse fibroblasts to neural 
stem/precursor-like cells when delivered by viral vectors. Here we extend these findings and demonstrate that 
transient ectopic insertion of the transcription factors SOX2 and PAX6 to adult human fibroblasts through use of 
non-viral plasmid transfection or protein transduction allows the generation of induced neural precursor (iNP) 
colonies expressing a range of neural stem and pro-neural genes. Upon differentiation, iNP cells give rise to 
neurons exhibiting typical neuronal morphologies and expressing multiple neuronal markers including tyrosine 
hydroxylase and GAD65/67. Importantly, iNP-derived neurons demonstrate electrophysiological properties of 
functionally mature neurons with the capacity to generate action potentials. In addition, iNP cells are capable of 
differentiating into glial fibrillary acidic protein (GFAP)-expressing astrocytes. This study represents a novel virus-
free approach for direct reprogramming of human fibroblasts to a neural precursor fate. 
of defined neural genes.[19-24] Further, neuronal cell subtypes 
such as functional spinal motor neurons [24] or dopaminergic 
neurons [20,22] have been generated by over-expression of 
specific transcription factor combinations. Cell culture systems 
utilizing induced mature neurons have potential in the areas of 
neurological disease modeling and drug development. However, 
a clear limitation of postmitotic induced neurons is their inability 
to expand once reprogrammed. To date expandable neural 
stem/precursor-like cells have only been generated from mouse 
fibroblasts by viral transduction of pluripotent and neural 
transcription factors.[14-18] We therefore investigated whether 
adult human fibroblasts could be directly reprogrammed to 
become neural precursor cells through ectopic expression of 
specific neural transcription factors using non-viral technologies.  
 
Different combinations of up to seven pluripotent and neural 
transcription factors have been identified to be capable of 
converting mouse fibroblasts into neural stem/precursor-like 
cells.[14-18] However, current knowledge regarding the key 
factors required to initiate neural stem/precursor fate 
determination in mouse and particularly in human cells is very 
limited. We hypothesized that genes which are involved in 
directing the differentiation of embryonic stem cells to the 
neuroectoderm lineage may also serve to reprogram human 
fibroblasts towards a neural stem/precursor-like state. Based on  
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previous work, [25,26] we identified the neural genes SOX2 
and PAX6 as playing a key role in the early stages of 
neurogenesis. SOX2 is a key factor in reprogramming cells to 
a pluripotent state [2,5] and is also associated with multipotent 
and unipotent stem cells.[27-29] PAX6 is essential for neural 
stem cell proliferation, multipotency and neurogenesis.[30] 
SOX2 and PAX6 are also expressed when embryonic stem 
cells undergo differentiation to a neural lineage.[25,27-32] 
Further, we have previously observed that neural induction of 
human embryonic stem cells results in mutually exclusive 
expression of PAX6 and the pluripotency factor OCT3/4, [25] 
indicating the involvement of PAX6 in neural lineage 
determination.  
 
The current study provides proof-of-concept that transient 
expression of SOX2 and PAX6 in adult human fibroblasts 
generates induced neural precursor-like (iNP) colonies 
expressing a range of neural stem and precursor genes, and 
immature neural markers. Upon differentiation, iNP colonies 
give rise either to mature neurons capable of generating 
action potentials upon current injection or to astrocytes as 
indicated by GFAP expression. This was achieved using 
either non-viral plasmid transfection or recombinant protein 
transduction technology alleviating concerns of insertional 
mutation associated with the use of genome-integrating viral 
vectors. Furthermore, we have optimized cell culture 
conditions allowing us to generate iNP colonies in the 
absence of an animal or human feeder cell layer, an 
essential requirement for the transfer of reprogrammed cell 
lines to clinical use. This technology provides a novel and 
ethically viable option for obtaining neural precursor cells for 
neurological research and clinical application. 
 
Materials & Methods 
Cell culture  
Human dermal fibroblast cells (HDF) isolated from the 
abdomen of two adult donors were obtained from Cell 
Applications Inc. and maintained in human HDF Growth 
Media (Cell Applications, Inc.). Plasmid DNA transfections 
and protein transduction were performed at passage 8 or 
earlier. Media was changed to proliferation medium 
comprising Neurobasal-A (Gibco), 1% D-glucose (Sigma-
Aldrich), 1% Penicillin/Streptomycin/Glutamine (Gibco), 2% 
B27 supplement (Gibco), 0.2% EGF (PeproTech), 0.08% 
FGF-2 (PeproTech), 0.2% Heparin (Sigma-Aldrich) and VPA 
(Sigma-Aldrich)  to a concentration of 1µM three days post-
transfection or post-transduction.  Media was changed three-
times weekly, and cells were replated regularly during iNP 
colony formation. 
Transcription factor delivery 
HDF cells at 1 × 105 cells per well were seeded in 
polystyrene 6-well plates (Nunc - Thermo Fisher Scientific) 
24 hrs prior to transfection or transduction. Media was 
changed to Optimem (Invitrogen) 2 hrs prior to the 
transfection procedure. Nonviral plasmid transfections were 
carried out using Lipofectamin LTX, Plus reagent (Invitrogen) 
and plasmid constructs encoding SOX2 , PAX6 or eGFP  
driven by a CMV promoter at a ratio 3:1:1 (v/v/w) and a total  
 plasmid DNA amount of 2µg. pCMV-SPORT6 comprising 
PAX6 cDNA was purchased from Invitrogen. SOX2 cDNA 
was purchased from Addgene and cloned into pEGFP-N1 
(Clontech) after removal of eGFP expression cassette from 
pEGFP-N1. Protein co-transductions were carried out in four 
transduction cycles using a mix of SOX2-TAT protein 
(PeproTech) and PAX6 protein (Abnova) or PE control 
protein (OzBioscience) with ProDeliverIn (OzBioscience) in a 
ratio 1:1 and a total protein amount of 5µg per transduction 
cycle. 
 
Quantitative RT- PCR 
Total RNA was isolated from 2.5 – 9.0 x 103 colonies of four 
independent iNP cell lines and two independent control cell 
lines by RNAeasy Mini Kit (Invitrogen), respectively. cDNA 
was synthesised from total RNA using Superscript reverse 
transcriptase (Invitrogen). Three independent duplex qPCR 
reactions were performed in triplicates for each independent 
cell line using the TaqMan system (Applied Biosystems) with 
ribosomal 18S rRNA as the internal standard and an 
equivalent of 4ng mRNA per reaction. 
 
Immunocytochemistry 
Immunocytochemical staining was carried out by standard 
procedures using the following human-specific primary 
antibodies: CD133 (Abcam), SOX2 (R&D Systems), PAX6 
(Covance), NGN2 (R&D Systems), MASH1 (Chemicon), 
TUJ-1 (Covance), NSE (DAKO), MAP2 (Chemicon), GAD65/67 
(Chemicon), TH (Chemicon), and GFAP (DAKO). 
 
Differentiation of iNP cells. 
Induced neural precursor colonies were generated by 
SOX2/PAX6 plasmid transfection and cultured for 6 weeks in 
neural precursor proliferation media medium comprising of 
NBA media, 2% B27, 1% D-glucose, 1% 
Penicillin/Streptomycin/Glutamine, 0.2% EGF, 0.08% FGF-2, 
0.2% Heparin, 1µM VPA and 25ng/ml Midkine (Peprotech). 
For neuronal differentiation, the cells were mechanically 
dissociated and transferred onto poly-ornithine/laminin-
coated (Sigma-Aldrich/ Invitrogen) surface following full 
colony formation and differentiated using a two-step protocol 
as previously described.[33] Briefly, cells were cultured in NBA 
media supplemented with 250ng/ml SHH (R&D systems), 
100ng/ml DKK1 (PeproTech), 20ng/ml BDNF (PeproTech) 
and 10μM Y27632 (Calbiochem). After 10 days, culture 
conditions were changed to NBA media containing 0.5mM 
dibutryl-cyclic AMP (Sigma-Aldrich), 0.5μM VPA, 20ng/ml 
BDNF and 10μM Y27632. 
 
For glial differentiation iNP colonies were mechanically 
dissociated following full colony formation and plated onto on 
fibronectin-coated surface. Astroglial differentiation was 
carried out in Glasgow minimum media (Sigma-Aldrich), 
supplemented with 10% FBS and 1% 
Penicillin/Streptomycin/Glutamine for 14 days. To promote 
oligodendroglial differentiation, cells were cultured in 3 
stages: NBA media supplemented with 2% B27, 1% D-
glucose,  1%  Penicillin / Streptomycin / Glutamine,   0.08%  
  R E S E A R C H   A R T I C L E
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 FGF-2 and 0.1% retinoic acid (Sigma-Aldrich) for 2 days, 
followed by DMEM/F12 media containing 0.5% N2 
supplement (Invitrogen), 10ng/mL FGF-2, 10ng/mL PDGF, 
0.5mM dibutryl-cyclic AMP for 4 days and DMEM/F12, 
30ng/mL 3,3',5-Triiodothyronine (Sigma-Aldrich), and 200µM 
Ascorbic acid (Sigma-Aldrich) for  an additional 4 days. 
Electrophysiology  
Whole cell patch clamping was performed as previously 
described [34] on iNP–derived neurons after 13, 21 and 30 
days of differentiation. Briefly, cells were bathed in artificial 
cerebrospinal fluid (in mM: 120 NaCl, 3 KCl, 2 CaCl2, 1.25 
NaH2PO4, 2 MgSO4, 20 glucose, 26 NaHCO3). Internal 
solution consisted of (in mM: 120 K gluconate, 40 HEPES, 5 
MgCl2, 2 NaATP, 0.3 NaGTP).  Cells were visualised on an 
Olympus BX51W1. Electrode resistance was 5 MΩ. Action 
potentials were induced in current clamp mode by a 10 ms 
current injection using a Multiclamp 700B Commander 
(Molecular Devices). Series resistance was constantly 
monitored and results were not included if significant 
variation (>20%) occurred during an experiment. Data 
acquisition and analysis was performed using pClamp9 
software. 
Results 
SOX2 and PAX6 convert human fibroblasts to neural 
precursor-like cells. 
SOX2 and PAX6 are key transcription factors in the 
development and maintenance of neural precursor cell 
identity. We therefore investigated the potential of ectopic 
SOX2 and PAX6 expression to directly convert adult human  
 fibroblasts to neural precursor-like cells. A homogenous 
population of adult human dermal fibroblasts  previously used 
to induce pluripotency by Yamanaka and colleagues, and 
shown to be free of cell cross-contamination was used in this 
study.[2,35] Protein transduction and non-viral plasmid 
transfection systems were utilized to provide transient ectopic 
expression of SOX2 and PAX6 in adult human fibroblasts 
(Figure 1A). Optimization of transfection / transduction 
efficiencies and control experiments were performed using 
either an eGFP plasmid or red-fluorescent phycoerythrin (PE) 
protein, respectively (Figures 1B, 1C).  
 
Neural differentiation protocols for human embryonic stem 
(hES) cells suggested the use of defined neural culture 
conditions in the absence of a mouse embryonic fibroblast 
(MEF) feeder layer to drive differentiation towards a 
neuroectodermal fate.[36,37] Thus, fibroblasts were allowed to 
recover in human fibroblast growth media for 3 days after 
SOX2/PAX6 delivery before being transferred to specific 
neural precursor cell culture conditions consisting of 
Neurobasal A media (NBA) with B27 supplement, FGF2, 
EGF and valproic acid (VPA). For both SOX2/PAX6 plasmid 
transfection and protein transduction, we observed significant 
changes in fibroblast density and morphology between days 
5 to 10 following transfer to neural precursor cell culture 
conditions. The changes occurred in a temporal order with 
decreasing cell density, altered morphology to a more 
compact shape and grouping of cells (Figure 2A). Strikingly, 
we observed the formation of domed and compact 
neurosphere-like cell colonies 4 weeks after protein delivery 
and 8 to 11 weeks after ectopic gene expression of SOX2  
  Maucksch C et al. JSRM/Vol8 No.3, 2012 
Figure 1: Timeline of protein / plasmid DNA delivery and generation of iNP cell colonies.  (A) Transcription factors were introduced into fibroblast cells by either plasmid 
DNA transfection or protein transduction. Plasmid DNA transfections were carried out in human dermal fibroblast growth media using Lipofectamin LTX  with a lipoplex 
incubation time of 24 hrs. Cells were subsequently cultured in human dermal fibroblast growth media for another 3 days before culture conditions were changed to NBA 
media to allow colony formation within 35-60 days. Protein transduction was performed in four cycles over a period of 12 days using ProDeliverin. Transductions were 
performed for 48 hrs in human dermal fibroblast growth media. Cells were cultured in human dermal fibroblast growth media for additional 24 hrs after transduction 
procedure. Transductions were carried out in four cycles of 72hrs each. (B) Phycoerythrin protein was utilised to optimize and assessed ProDeliverIn mediated protein 
transduction into human dermal fibroblast cells. FACS analysis revealed a protein transduction efficiency of 54%. (C) Nonviral plasmid transfection was optimized to an 
efficiency of 12% using pCMV-EGFP-N1 plasmid and Lipofectamine LTX. Scale bars: 100µm 
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and PAX6. Colonies induced by plasmid transfection and 
protein transduction both appeared with a regular, round 
morphology with a diameter between 50 - 500μm (Figure 
2B). Interestingly, fibroblasts transfected with eGFP control 
plasmid or transduced with PE control protein and cultured in 
neural culture conditions for up to 11 weeks occasionally 
developed cell colony structures (Figure 2C). However, 
colony formation in control cultures occurred significantly 
later, with lower efficiency and a less uniform morphology 
than SOX2/PAX6-induced colonies. In contrast, fibroblasts 
cultured in human fibroblast growth media only grew in a 
monolayer and showed no colony formation at any time point 
(Figure 2D). 
To investigate the proliferative capability of induced cell 
colonies, primary colonies were mechanically dissociated 
and replated as single cells. Within 2-3 days, individual cells 
generated secondary colonies with increased cell diameter 
(Figure 2E). Repeated dissociation and replating gave rise to 
tertiary and quaternary colonies. Formation and growth of 
uniform colonies could be increased and accelerated by  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
regular replating of cells to an efficiency of 0.05% of the 
number of fibroblasts initially transfected/transduced with 
SOX2/PAX6. Regular cell replating also decreased the time 
required for full colony formation to 5 - 8 weeks following 
plasmid transfection.  
These results demonstrate that transient ectopic delivery of 
SOX2 and PAX6 can direct the generation of uniform 
induced colonies resembling neural precursor cell 
neurosphere colony formation.[38,39] Furthermore, colony 
formation was achieved in the absence of a MEF feeder cell 
layer. 
Induced colonies show neural precursor-like 
characteristics.  
To assess if cell colonies induced by transient ectopic SOX2 
and PAX6 expression exhibited features of neural precursor 
cells, we investigated the transcriptional signature and 
phenotypic characteristics of SOX2/PAX6 induced colonies 
compared to eGFP or PE controls. Total RNA from three fully 
developed independent colony lines was isolated at 65, 75 or 
85 days respectively following plasmid transfection, and an 
additional colony line was isolated 27 days following protein 
transduction. A range of neural stem cell and precursor 
genes and positional markers within the neuroectodermal 
tube were analyzed and compared by quantitative PCR 
(Figure 3A). We observed that colonies transduced with 
SOX2 and PAX6 protein exhibited SOX2 and PAX6 mRNA 
expression in contrast to the PE control (Figure 3A). Due to 
the transient nature of protein transduction in contrast to 
delivery of genetic material, this observation strongly 
indicates the activation of endogenous SOX2 and PAX6 
mRNA expression by ectopic protein transduction. Similar to 
protein transduction, SOX2 and PAX6 mRNA expression 
levels were found in independent SOX2/PAX6 induced 
colony  lines  formed  at  different  time  points  after transient  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
plasmid DNA transfection with the highest relative expression 
observed in colony lines isolated 65 days after transfection 
and gradually decreasing in colony lines isolated 75 and 85 
days post transfection (Figure 3A). Quantitative PCR analysis 
further demonstrated elevated mRNA expression levels of 
the neural markers neurogenin2 (NGN2), SOX1, HOXB9, 
NKX6.1 and SIX3. eGFP- and PE-treated controls showed 
either no mRNA expression or relatively lower levels of these 
markers (Figure 3A). In contrast, HES1 and IRX3 mRNA 
levels were reduced in iNP colonies generated by 
SOX2/PAX6 protein transduction compared to PE control 
cells (Figure 3A). Transcriptional profile determination of 
three independent colony lines generated by plasmid 
transfection revealed  
  R E S E A R C H   A R T I C L E
Figure 2: Generation of induced neural precursor colonies from human fibroblasts. (A) Temporal change of fibroblast morphology from 1 - 5 weeks following 
SOX2/PAX6 delivery (wfd). (B) Fully developed iNP colonies 6 weeks after SOX2/PAX6 delivery. (C) Fibroblast morphology 11 weeks after either eGFP plasmid 
transfection (TF) or PE protein transduction (TD). (D) Untreated fibroblasts maintained their morphology when cultured in human dermal fibroblast growth media. 
(E) Secondary iNP colonies reformed within 3 days following mechanical dissociation. Scale bars: 100 µm. 
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a distinctive pattern of neural gene expression dependent on 
the duration following delivery of SOX2/PAX6 (Figure 3A). 
Colony lines analyzed 65 days following SOX2/PAX6 delivery 
exhibited elevated mRNA expression levels of SOX2, PAX6, 
SOX1, HOXB9, NKX6.1 and reduced HES1 and IRX3 
expression relative to eGFP controls. Conversely, colony 
lines analyzed at 85 days showed a shift towards higher 
HES1, IRX3, SIX3 and lower PAX6, SOX2, NGN2 and SOX1 
expression levels compared to the colony lines analysed 65 
days post SOX2/PAX6 treatment. In accordance, colony lines 
examined 75 days following SOX2/PAX6 treatment displayed 
intermediate transcription factor expression levels. This 
suggests a progressive transition of neural gene expression 
towards a more mature phenotype over time following the 
initial induction of SOX2 and PAX6 expression. The gene 
expression pattern of the iNP colony lines was also 
compared to noggin-primed hES-derived neural precursor 
(hNP) cells (Figure 3A). Quantitative PCR analysis 
demonstrated higher mRNA expression levels of SOX2, 
PAX6, SOX1 and NGN2 in hNP cells compared to iNP cells. 
This may reflect either the presence of partially 
reprogrammed iNP cells or a population of non-
reprogrammed fibroblasts present in the culture. 
It has been shown that the putative pluripotent marker 
OCT3/4 is expressed in neural stem cells and that 
expression of NANOG is partially regulated by a SOX2-
OCT3/4 complex.[40-42] Thus, we assessed if expression of 
SOX2 in iNP colonies is associated with the expression of 
OCT3/4 and/or NANOG. OCT3/4 mRNA levels were found to 
be up-regulated in iNP colony lines isolated 65 days after
plasmid transfection and in colony lines generated by protein 
transduction when compared to controls. However, analysis 
of iNP colony lines isolated 75 days following SOX2/PAX6 
gene delivery revealed no increase in OCT3/4 expression 
(Figure 3A). Similar results were found for NANOG, with an 
increase in NANOG mRNA expression only observed in iNP 
colony lines isolated at 65 or 75 days post transfection and in 
protein-treated colony lines when compared to controls 
(Figure 3A).  
To further assess the expression of neural precursor 
markers, immunocytochemical analysis was conducted. 
Positive staining of iNP colonies for SOX2, PAX6 and NGN2 
confirmed qPCR results at the protein level (Figure 3B). 
However, irregular expression patterns were observed in a 
small number of colonies which may also suggest partial 
reprogramming. Combined, these results demonstrate that 
transient expression of SOX2 and PAX6 in human fibroblasts 
induce cell colonies that display the transcriptional and 
phenotypic signature of neural precursor cells. 
 
Induced neural precursor colonies have the capacity to 
differentiate into mature neurons and astrocytes. 
To investigate the capacity of iNP colonies to differentiate 
into mature neurons and glial cells, we tested several 
differentiation conditions. We have previously demonstrated 
efficient differentiation of neural precursor cells derived from 
the subventricular zone of the adult rat brain using standard 
neural differentiation media.[43,44] As such, induced neural
  Maucksch C et al. JSRM/Vol8 No.3, 2012 
Figure 3: Characterization of induced neural precursor cells. (A) Gene expression profiles of independent iNP colony lines generated by protein 
transduction (TD) or plasmid transfection (TF) at different time points post transcription factor delivery compared to eGFP transfection (eGFP), PE 
transduction (PE) and hESC-derived neural precursor cell (hNP) controls. Heatmap represents the average cycle threshold values normalized to internal 
ribosomal 18S rRNA control (∆Ct) obtained from three independent qPCR reactions, respectively. (B) Expression of SOX2, PAX6 and NGN2 in iNP colonies. 
Scale bars: 25 µm. 
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precursor colonies generated by plasmid transfection were 
cultured in standard neural differentiation media for two 
weeks. Immunocytochemical analysis demonstrated co-
expression of the pro-neural markers MASH1 and NGN2 
(Figure 4A) and enduring expression of SOX2 and PAX6 
(Figure 4B) following two weeks of differentiation. However, 
iNP colonies did not differentiate into either neurons or glia 
as indicated by a lack of staining for the markers MAP2, 
GFAP and RIP, and remained in their colony assemblage.  
Several studies suggest the use of sonic hedgehog (SHH) to 
efficiently regulate neuronal differentiation of hES-derived 
neurospheres.[33,45] Thus, we examined whether a modified 
two-staged differentiation protocol which has previously been 
demonstrated to generate mature neurons from iPSCs[33] 
could drive efficient neuronal differentiation of iNP cells. 
Induced neural precursor colonies were mechanically 
dissociated and cultured in neural differentiation media 
supplemented with SHH, DKK1, BDNF and Y27632 for 10 
days. The cells were subsequently exposed to dibutryl-cyclic 
AMP, VPA, BDNF and Y27632. After 13 days of 
differentiation a proportion of iNP cells developed a neuron-
like morphology with tangential and radial processes. 
Continued differentiation up to 30 days resulted in an 
increase in the proportion of iNP cells exhibiting a typical 
neuronal morphology and the generation of a more mature 
phenotype with the appearance of multiple arborizing 
dendrites and a single axon from the cell soma. Further 
confirmation of neuronal differentiation was demonstrated by 
robust expression of the neuronal markers TUJ-1, NSE and 
MAP2 (Figure 4C). A population of iNP-derived neurons also 
expressed the GABAergic marker GAD65/67 (Figure 4D) or the 
catecholaminergic marker tyrosine hydroxylase (TH) (Figure 
4E). To determine whether iNP-derived neurons exhibit 
excitable membrane properties similar to mature neurons, 
whole cell patch clamping was performed. Initial recordings  
performed after 13 or 21 days of differentiation revealed the 
presence of functionally immature cells. The average resting 
membrane potentials were depolarized (-39.8 ± 4.3 mV, n = 
6 cells and -38.5 ± 3.3 mV, n = 11 cells respectively) and no 
action potentials could be evoked by current injection. 
However, after 30 days differentiation functionally mature 
neurons were able to fire single action potentials upon 
current injection (Figures 4F, 4G). Moreover, the average 
resting membrane potential had shifted to significantly more 
hyperpolarised potentials (-50.8 ± 2.9 mV, n = 15 cells) 
compared to recordings performed at days 13 and 21 (p < 
0.05). This was accompanied by a significant increase in 
membrane capacitance (from 164.5 ± 48.0 pF to 869.3 ± 
334.2 pF; p < 0.05) consistent with significant increases in 
the amount of neuronal membrane as the cells develop a 
more mature neuronal morphology.  
To determine the glial differentiation potential of iNP colonies, 
we mechanically dissociated iNP cells and cultured them in 
astroglial or oligodendroglial differentiation media, 
respectively. We observed a small proportion (< 1%) of cells 
expressing the astrocytic marker GFAP and exhibiting an 
astrocyte-like morphology after 14 days of differentiation 
(Figure 4H). However, no cells were found expressing the 
oligodendrocyte markers O4 or RIP when cultured under 
oligodendroglial conditions (data not shown).  
 
Discussion 
The current study demonstrates a method to directly convert 
adult human fibroblasts into neural precursor cells. This was 
achieved by exogenous application of the transcription 
factors SOX2 and PAX6. In order to avoid genome 
interference, non-viral plasmid transfection or protein 
transduction techniques were chosen for ectopic expression 
  R E S E A R C H   A R T I C L E
Figure 4: Neuronal and astroglial differentiation of induced neural precursor cells. Co-expression of (A) MASH1 and NGN2 and (B) SOX2 and PAX6 in 
differentiating iNP colonies. (C) iNP-derived neurons express the neuronal markers TUJ1, NSE, and MAP2. Arrows indicate cells exhibiting a typical neuronal 
morphology. (D) iNP-derived neurons express GAD65/67 or (E) tyrosine hydroxylase (TH) with NSE co-expression. (F) Image of iNP-derived neuron undergoing 
patch clamp recording after 30 days of differentiation. (G) Representative trace of action potential generated in response to current injections from iNP-derived 
neuron after 30 days of differentiation. (H) Astrocytes derived from iNP cells express the astroglial marker GFAP. Scale bars: 25 µm.  
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of SOX2 and PAX6. The time period required for fibroblasts 
to form iNP colonies was comparable with previous studies 
using protein transduction and plasmid transfection to 
generate iPSCs, indicating a significant impact of 
methodology on the reprogramming process.[46,47] In contrast, 
the efficiency of iNP colony generation of 0.05% of the initial 
transfected/transduced fibroblast cells was considerably 
higher than the induction of iPSCs using non-viral 
methods.[46,47] 
Others have recently demonstrated the direct generation of 
neural stem and precursor cells from either embryonic [14-17] 
or adult [18] mouse fibroblast cells. This was achieved by viral 
transduction of either the four pluripotent transcription factors 
OCT3/4, SOX2, KLF4, and C-MYC in a transient manner [15], 
or viral transduction of up to eleven neural stem cell-
associated factors.[16-18] In two other studies the proto-
oncogene BMI1 was identified as a key factor in 
reprogramming mouse fibroblasts into either induced neural 
stem or precursor cells.[17,18] Interestingly, Han and 
colleagues [14] observed morphological transformation of 
mouse embryonic fibroblasts 2-3 weeks after viral delivery of 
SOX2 and PAX6. However, the cells were not analyzed or 
cultured to a stage later than 3 weeks post transduction. 
Further, a recent study has demonstrated the reprogramming 
of mouse embryonic fibroblasts and human fetal foreskin 
fibroblasts into multipotent neural stem-like cells following 
retroviral transduction of SOX2 when cultured on a mitomycin 
C-treated MEF feeder layer.[48] This is the first study to 
demonstrate the generation of neural stem-like cells from 
human fibroblasts and supports the findings presented in the 
current study. Using both SOX2 and PAX6, we now extend 
these findings to the generation of iNP cells from adult 
human fibroblasts by non-viral delivery without the 
requirement of a MEF feeder layer. 
In the current study, iNP colonies exhibited elevated 
expression of the neural stem and pro-neural markers SOX1, 
SOX2, PAX6, NGN2, HOXB9 and NKX6.1, with down-
regulation of HES1 and IRX3 mRNA after SOX2/PAX6 
protein delivery or 65 days following plasmid transfection. 
Due to the transient nature of both the plasmid transfection 
and protein transduction procedures utilized in this study, we 
were able to determine the effect of endogenous SOX2 and 
PAX6 mRNA expression in the resultant iNP cells. 
Interestingly, temporal analysis of mRNA expression 
revealed an inverse shift of expression with reduced relative 
mRNA levels of PAX6, SOX2, NGN2 and SOX1 and 
concurrent elevation of HES1, IRX3, SIX3 expression in 
independent colonies analyzed at 75 and 85 days compared 
to 65 days following SOX2/PAX6 delivery. PAX6 has 
previously been demonstrated to regulate NGN2 expression 
in a concentration-dependent manner [49], reflected by the 
temporal correlation of PAX6 and NGN2 expression 
observed in iNP colonies. Further, down-regulation of the 
transcriptional repressor HES1, with opposing functions to 
PAX6, is in accordance with PAX6 up-regulation and 
PAX6/HES1 regulation of neurogenesis. [30] Elevated mRNA 
expression of the putative pluripotent markers OCT3/4 and 
NANOG was also detected with gradually decreasing levels 
in cells from 65 to 75 days following SOX2/PAX6 delivery. 
OCT3/4 and NANOG expression in iNP cells was in 
agreement with studies demonstrating that SOX2 and OCT-
3/4 work cooperatively to regulate their own transcription by a 
positive feedback loop, and that OCT3/4 and SOX2 in turn  
activate NANOG expression.[40,50] Interestingly, 85 days post 
SOX2/PAX6 transfection OCT3/4 levels were found to be 
increased whereas NANOG and SOX2 expression levels 
were decreased compared to 75 days post transfection. 
To prove the capacity for iNP cells generated by SOX2/PAX6 
delivery to form mature neurons, we tested several 
differentiation conditions and assessed the expression of 
mature neuronal markers as well as the electrophysiological 
properties of differentiated iNP cells. Mature neurons were 
able to be derived from iNP colonies by a differentiation 
protocol which included SHH and BDNF. Differentiated cells 
showed a distinctive neuronal morphology including multiple 
arborizing dendrites and expression of the neuronal markers 
TUJ1, NSE and MAP2 with a population of iNP-derived 
neurons expressing TH or GAD65/67. Most importantly, iNP-
derived neurons demonstrated the ability to fire action 
potentials in response to current injection. Measurement of 
the electrical properties of iNP-derived neurons at different 
time points during differentiation confirmed a gradual 
maturation process over a period of 30 days. In addition, iNP 
cells were able to give rise to a small population of astrocytes 
as demonstrated by staining for the astrocytic marker GFAP. 
However, we were not able to detect oligodendroglial 
differentiation. Lujan and colleagues [16] also observed a lack 
of oligodendrocyte differentiation from neural precursor cells 
which were generated from mouse embryonic fibroblasts by 
viral delivery of the two transcription factors SOX2 and 
FOXG. Oligodendroglial differentiation was only achieved by 
addition of BRN2. It would be interesting to further assess 
whether a combination of BRN2, PAX6 and Sox2 can also 
successfully convert human fibroblasts to iNP cells capable 
of oligodendrocyte differentiation. 
 
Conclusion 
The current study provides proof-of-concept that transient 
expression of the neural transcription factors SOX2 and 
PAX6 directly converts adult human fibroblasts into neural 
precursor-like cells. The use of either non-viral plasmid 
transfection or recombinant protein transduction alleviates 
concerns of insertional mutation associated with the use of 
genome-integrating viral vectors. Further studies will be 
necessary to thoroughly optimize the efficiency for human 
iNP cell generation and neural differentiation. Such studies 
will facilitate the application of this method for future use for 
in vitro disease modeling, drug screening and as a ready 
source of human autologous neural precursor cells for cell 
replacement therapy. 
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